Continental Advisors LLC Biogen Inc. Transaction History

Continental Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$264.77 - $305.71 $629,358 - $726,672	-2,377 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$220.06 - $304.07 $176,048 - $243,256	-800 Reduced 25.18%	2,377 $705,000
Q1 2019 May 14, 2019	SELL	$216.71 - $338.96 $113,339 - $177,276	-523 Reduced 14.14%	3,177 $751,000
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $1.03 Million - $1.31 Million	3,700 New	3,700 $1.11 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Continental Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Continental Advisors LLC with notifications on news.